155 related articles for article (PubMed ID: 35560362)
21. Efficient dose-volume histogram-based pretreatment patient-specific quality assurance methodology with combined deep learning and machine learning models for volumetric modulated arc radiotherapy.
Gong C; Zhu K; Lin C; Han C; Lu Z; Chen Y; Yu C; Hou L; Zhou Y; Yi J; Ai Y; Xiang X; Xie C; Jin X
Med Phys; 2022 Dec; 49(12):7779-7790. PubMed ID: 36190117
[TBL] [Abstract][Full Text] [Related]
22. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA.
Alhazmi A; Gianoli C; Neppl S; Martins J; Veloza S; Podesta M; Verhaegen F; Reiner M; Belka C; Parodi K
Phys Med Biol; 2018 May; 63(11):115002. PubMed ID: 29714714
[TBL] [Abstract][Full Text] [Related]
23. Gamma analysis dependence on specified low-dose thresholds for VMAT QA.
Song JH; Kim MJ; Park SH; Lee SR; Lee MY; Lee DS; Suh TS
J Appl Clin Med Phys; 2015 Nov; 16(6):263-272. PubMed ID: 26699582
[TBL] [Abstract][Full Text] [Related]
24. A study on correlation between 2D and 3D gamma evaluation metrics in patient-specific quality assurance for VMAT.
Rajasekaran D; Jeevanandam P; Sukumar P; Ranganathan A; Johnjothi S; Nagarajan V
Med Dosim; 2014; 39(4):300-8. PubMed ID: 24910246
[TBL] [Abstract][Full Text] [Related]
25. A hybrid method to improve efficiency of patient specific SRS and SBRT QA using 3D secondary dose verification.
Baltz GC; Manigold R; Seier R; Kirsner SM
J Appl Clin Med Phys; 2023 Mar; 24(3):e13858. PubMed ID: 36583305
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Delta
Tang D; Yang Z; Dai X; Cao Y
Technol Cancer Res Treat; 2020; 19():1533033820945816. PubMed ID: 32720589
[TBL] [Abstract][Full Text] [Related]
27. Comparing measurement-derived (3DVH) and machine log file-derived dose reconstruction methods for VMAT QA in patient geometries.
Tyagi N; Yang K; Yan D
J Appl Clin Med Phys; 2014 Jul; 15(4):4645. PubMed ID: 25207396
[TBL] [Abstract][Full Text] [Related]
28. Pre-treatment 2D and 3D dosimetric verification of volumetric arc therapy. A correlation study between gamma index passing rate and clinical dose volume histogram.
Szczurek L; Juszkat R; Szczurek J; Turek I; Sosnowski P
PLoS One; 2019; 14(8):e0221086. PubMed ID: 31408486
[TBL] [Abstract][Full Text] [Related]
29. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
30. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
[TBL] [Abstract][Full Text] [Related]
31. Statistical analysis of IMRT dosimetry quality assurance measurements for local delivery guideline.
Chung JB; Kim JS; Ha SW; Ye SJ
Radiat Oncol; 2011 Mar; 6():27. PubMed ID: 21439096
[TBL] [Abstract][Full Text] [Related]
32. A robust approach to establish tolerance limits for the gamma passing rate-based patient-specific quality assurance using the heuristic control charts.
Xiao Q; Bai L; Li G; Zhang X; Li Z; Duan L; Peng R; Zhong R; Wang Q; Wang X; Bai S
Med Phys; 2022 Feb; 49(2):1312-1330. PubMed ID: 34778963
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric verification for intensity-modulated arc therapy plans by use of 2D diode array, radiochromic film and radiosensitive polymer gel.
Hayashi N; Malmin RL; Watanabe Y
J Radiat Res; 2014 May; 55(3):541-52. PubMed ID: 24449714
[TBL] [Abstract][Full Text] [Related]
34. Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method.
Bresciani S; Di Dia A; Maggio A; Cutaia C; Miranti A; Infusino E; Stasi M
Med Phys; 2013 Dec; 40(12):121711. PubMed ID: 24320497
[TBL] [Abstract][Full Text] [Related]
35. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms.
Laugeman E; Heermann A; Hilliard J; Watts M; Roberson M; Morris R; Goddu S; Sethi A; Zoberi I; Kim H; Mutic S; Hugo G; Cai B
J Appl Clin Med Phys; 2020 Jul; 21(7):39-48. PubMed ID: 32368862
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive and clinical-oriented evaluation criteria based on DVH information and gamma passing rates analysis for IMRT plan 3D verification.
Yi X; Lu WL; Dang J; Huang W; Cui HX; Wu WC; Li Y; Jiang QF
J Appl Clin Med Phys; 2020 Aug; 21(8):47-55. PubMed ID: 32436351
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of patient DVH-based QA metrics for prostate VMAT: correlation between accuracy of estimated 3D patient dose and magnitude of MLC misalignment.
Kadoya N; Saito M; Ogasawara M; Fujita Y; Ito K; Sato K; Kishi K; Dobashi S; Takeda K; Jingu K
J Appl Clin Med Phys; 2015 May; 16(3):5251. PubMed ID: 26103486
[TBL] [Abstract][Full Text] [Related]
39. Assessment of radiobiological metrics applied to patient-specific QA process of VMAT prostate treatments.
Clemente-Gutiérrez F; Pérez-Vara C; Clavo-Herranz MH; López-Carrizosa C; Pérez-Regadera J; Ibáñez-Villoslada C
J Appl Clin Med Phys; 2016 Mar; 17(2):341-367. PubMed ID: 27074458
[TBL] [Abstract][Full Text] [Related]
40. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
Masi L; Doro R; Favuzza V; Cipressi S; Livi L
Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
